Please Wait.....
Report
Japan Pharmaceutical 3PL - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-01-16 I 150 Pages I Mordor Intelligence
Japan Pharmaceutical 3PL Market Analysis
The Japan Pharmaceutical 3PL Market is expected to grow from USD 4.25 billion in 2025 to USD 4.44 billion in 2026 and is forecast to reach USD 5.55 billion by 2031 at 4.55% CAGR over 2026-2031.
Japan's strict Good Distribution Practice (GDP) rules, an aging population that relies heavily on biologics, and rising demand for cell and gene therapies are steering drug makers toward outsourced logistics partners. Providers able to offer temperature-controlled transport from -196 C to ambient conditions, real-time shipment monitoring, and nationwide regulatory expertise are gaining share. Service differentiation now hinges on AI-enabled route planning, IoT sensors that verify cold-chain integrity, and carbon-neutral warehousing solutions aligned with Japan's 2050 decarbonization goal. Intensifying investment in biologics plants around Yokohama, Osaka, and Fukuoka keeps domestic transport volumes high while stimulating double-digit growth in cross-border flows of clinical trial materials and high-value finished drugs. Regulatory scrutiny after bid-rigging cases among wholesalers has raised compliance costs, yet it has also strengthened customer preference for logistics specialists with flawless audit records.
Japan Pharmaceutical 3PL Market Trends and Insights
Growing demand for temperature-controlled biologics & vaccines
Biologics now outpace small-molecule drugs in revenue growth, forcing shippers to deploy ultra-low temperature packaging that secures potency from factory to patient. AGC Biologics' USD 350.5 million Yokohama plant dedicated to cell therapies has already spurred contracts for ?80 C storage and dry-vapor dewars on domestic trunk routes. Panasonic's VIXELL containers, certified for ??70 C stability over 18 days, enable airlines such as ANA Cargo to obtain IATA CEIV Pharma accreditation, a prerequisite for global biologics traffic. Real-time sensors that log excursions feed analytics engines, allowing carriers to adjust routing before spoilage occurs. As a result, cold-chain premiums often exceed ambient rates by 20-30%, improving margins for GDP-licensed 3PLs.
Outsourcing trend among Japanese pharma manufacturers
Government pricing reforms have squeezed producer margins, and quality lapses at generics firms heightened the risk of managing logistics in-house. Membership in the Japan CMO Association has doubled since 2021 as producers hand off packaging, storage, and compliant shipping to 3PLs. Meiji Seika Pharma's decision to export 3 billion tablets annually from its Indian plant while using GDP-qualified Japanese hubs underscores the new mixed-location model. Capital light strategies free R&D budgets while guaranteeing audit-ready documentation, making outsourcing the norm for both legacy brands and biosimilar challengers.
GDP compliance cost & qualified-labour shortage
PMDA audits require validated chambers, backup generators, and written SOPs, lifting entry investment to nearly USD 12 million for a mid-sized facility. A shortage of GDP-trained technicians pushes median annual wages 18% above general warehouse staff. Smaller regional 3PLs often fail mock inspections, prompting mergers or exits that reduce competitive intensity in niche lanes.
Other drivers and restraints analyzed in the detailed report include:
Surge in pharma e-commerce & last-mile cold-chain demandAI-driven spoilage reduction & route optimizationScarcity & cost of urban cold-storage real estate
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Domestic transportation management accounted for 42.15% of the Japan pharmaceutical 3PL third-party logistics market in 2025 thanks to dense production clusters in Kanto and Kansai linked to over 8,000 hospitals and 59,000 pharmacies nationwide. With the Japan pharmaceutical 3PL third-party logistics market size dependent on daily replenishment cycles, carriers operate temperature-segregated box trucks equipped with real-time GPS and door sensors. Same-day lead times have become standard, and regulatory expectations compel providers to maintain onboard printers for tamper-evident labels on every stop.
International transportation management, although smaller, is rising at 5.25% CAGR as Japanese drug makers expand global clinical trials and biologics imports. The segment's premium stems from double-layer packaging, redundant dataloggers, and compliance with EU GDP and U.S. CFR-21. Nippon Express leverages a network of 36 GDP-certified stations across 25 countries to orchestrate lane-temperature profiles before flight booking, minimizing excursion risk. These capabilities attract sponsors shipping investigational cell therapies, where one deviation can annul an entire batch valued at USD 0.5 million.
Pharmaceutical manufacturers contributed 44.10% of the Japanese pharmaceutical 3PL third-party logistics market in 2025, a testament to their legacy dominance and the continued need for bulk distribution to wholesalers. Rising serialization and recall preparedness have made external 3PLs indispensable for batch traceability, leading to multi-year master service agreements covering packaging, warehousing, and reverse logistics.
Biotech and biosimilar producers form the fastest-growing customer group at 6.55% CAGR, reflecting government incentives for regenerative medicine. Start-ups lacking in-house logistics prefer asset-light partnerships, often employing 3PLs as early as Phase I trials to ensure chain-of-identity records. Clinical research sponsors, specialty pharmacies, and direct-to-patient platforms increasingly demand micro-fulfillment capabilities, widening the revenue base for agile providers.
The Japan Pharmaceutical 3PL Third-Party Logistics Market Report is Segmented by Service Type (Domestic Transportation Management, and More, End User (Pharmaceutical Manufacturers, Biotech & Biosimilar Manufacturers, and More), Product Type (Prescription Drugs, OTC & Consumer Health Products, and More), and Geography (Hokkaido & Tohoku, Kanto, Chubu, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Nippon Express DHL Logistics Kuehne + Nagel Kerry Logistics CEVA Logistics FedEx Yusen Logistics LOGISTEED Yamato Transport Sagawa Express Nissin Corporation Suzuyo Co. Mitsubishi Logistics Sankyu Inc. Kintetsu World Express (KWE) NNR Global Logistics Suzuken Group Itochu Logistics Nichirei Logistics Group Kokusai Express
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing demand for temperature-controlled biologics & vaccines
4.2.2 Outsourcing trend among Japanese pharma manufacturers
4.2.3 Surge in pharma e-commerce & last-mile cold-chain demand
4.2.4 Drone-based rural delivery pilots
4.2.5 Carbon-neutral cold-chain investments
4.2.6 AI-driven spoilage reduction & route optimisation
4.3 Market Restraints
4.3.1 GDP compliance cost & qualified-labour shortage
4.3.2 Scarcity & cost of urban cold-storage real estate
4.3.3 Rising electricity cost for ultra-low temp warehouses
4.3.4 Disaster-risk insurance & contingency cost
4.4 Value/Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces
4.7.1 Bargaining Power of Suppliers
4.7.2 Bargaining Power of Buyers
4.7.3 Threat of New Entrants
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
4.8 Pharmaceutical E-Commerce Market in Japan
4.9 Spotlight on Pharma Packaging - Global & Japan Trends
4.10 Impact of COVID-19 and Geo-Political Events on the Market
5 Market Size & Growth Forecasts (Value)
5.1 By Service Type
5.1.1 Domestic Transportation Management (DTM)
5.1.1.1 Roadways
5.1.1.2 Railways
5.1.1.3 Airways
5.1.1.4 Waterways
5.1.2 International Transportation Management (ITM)
5.1.2.1 Roadways
5.1.2.2 Railways
5.1.2.3 Airways
5.1.2.4 Waterways
5.1.3 Value-Added Warehousing & Distribution (VAWD)
5.2 By Temperature Type
5.2.1 Cold Chain
5.2.2 Non-cold Chain
5.3 By End User
5.3.1 Pharmaceutical Manufacturers
5.3.2 Biotech & Biosimilar Manufacturers
5.3.3 Clinical Research & Trial Sponsors
5.3.4 Hospitals & Retail Pharmacies
5.3.5 Healthcare Distributors & Wholesalers
5.3.6 E-pharmacies & Direct-to-Patient Services
5.3.7 Others
5.4 By Product Type
5.4.1 Prescription Drugs
5.4.2 OTC & Consumer Health Products
5.4.3 Biopharmaceuticals & Biosimilars (ex-CGT)
5.4.4 Cell & Gene Therapies
5.4.5 Vaccines & Blood-derived Products
5.4.6 Veterinary Pharmaceuticals & Animal Health Products
5.4.7 Medical Devices, Diagnostics & Combination Products
5.4.8 Clinical-trial Materials (Investigational Medicinal Products)
5.4.9 Others
5.5 By Region (Japan)
5.5.1 Hokkaido & Tohoku
5.5.2 Kanto
5.5.3 Chubu
5.5.4 Kansai
5.5.5 Chugoku & Shikoku
5.5.6 Kyushu & Okinawa
6 Competitive Landscape
6.1 Market Concentration
6.2 Strategic Moves (M&A, JV, Investments)
6.3 Market Share Analysis
6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, Recent Developments)
6.4.1 Nippon Express
6.4.2 DHL Logistics
6.4.3 Kuehne + Nagel
6.4.4 Kerry Logistics
6.4.5 CEVA Logistics
6.4.6 FedEx
6.4.7 Yusen Logistics
6.4.8 LOGISTEED
6.4.9 Yamato Transport
6.4.10 Sagawa Express
6.4.11 Nissin Corporation
6.4.12 Suzuyo Co.
6.4.13 Mitsubishi Logistics
6.4.14 Sankyu Inc.
6.4.15 Kintetsu World Express (KWE)
6.4.16 NNR Global Logistics
6.4.17 Suzuken Group
6.4.18 Itochu Logistics
6.4.19 Nichirei Logistics Group
6.4.20 Kokusai Express
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security